Nephro Care India, a leading multi-speciality healthcare provider in East India, is planning to raise Rs 35-40 crore through an initial public offering (IPO), subject to NSE Emerge approval. This strategic move will allow Nephro Care to expand its operations across India.

The company plans to use the net proceeds from the IPO to establish a multi-speciality hospital named 'Vivacity Multi Speciality Hospital' in Madhyamgram, Kolkata, West Bengal.

The remaining capital will be used for general corporate purposes. The new hospital, a unit of Nephro Care, will reportedly include 100 inpatient beds, including a 30-bed critical care unit with ICU, HDU, RTU, and NICU facilities. Vivacity will offer treatment services in various disciplines, including cardiology, medical oncology, gastroenterology, gynecology, and an advanced renal transplant unit, making it the most advanced facility of its kind in East India.

The IPO will consist of a fresh issuance of 45.84 lakh equity shares with a face value of Rs 10 each. Nephro Care's financial performance is on the rise. The company posted a revenue of Rs 19.90 crore and a profit (PAT) of Rs 3.4 crore in the first nine months of FY 2023-24, compared to a revenue of Rs 17.09 crore and a profit (PAT) of Rs 1.94 crore in FY 2022-23.